GlaxoSmithKline (GSK) has agreed to acquire Rapt Therapeutics for $2.2 billion, the companies said today, in a deal intended to bolster the buyer’s pipeline with Rapt’s ozureprubart (RPT904), a ...

The company applies AI to optimize molecules across discovery and production with aims to contribute to the rebuilding of U.S.-based drug innovation and manufacturing.

Astellas Gene Therapies remains intent on treating X-linked Myotubular Myopathy (XLMTM) through a gene therapy—but instead of AAV-based resamirigene bilparvovec (AT132), Astellas is now partnering ...

Data from several dozen human volunteers showed that blocking sEH raised epoxy-oxylipin levels and reduced harmful immune ...

Stopping cancer cells from entering a soft biomechanical state could help the immune system clear dormant cancer metastasis.

Researchers suggest that wound dressings infused with antioxidants such as catalase could be an effective future treatment.

Scientists first read the human genome, a three-billion-letter biological book, in April 2003. Since then, researchers have steadily advanced the ability to write DNA, moving far beyond single-gene ...

Sarepta Therapeutics saw its stock skid 11% after the company announced preliminary unaudited 2025 sales results that missed analyst forecasts for its marketed Elevidys® (delandistrogene ...

Using CLASSIC, Rice researchers realized that circuits are variable, having multiple pathways to elicit the same outcome.

UC San Diego leads a $25.8 million ARPA-H funded project to 3D bioprint patient-specific human livers, aiming to eliminate organ shortages.

Following the closing, the Emeryville and Berkeley, CA, biologics manufacturing facilities will be transferred to Zydus.

Biologics manufacturers urged to develop a chemistry, manufacturing, and controls (CMC) management strategy for reference material early.